Kyntra Bio Inc (KYNB) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Kyntra Bio Inc   (NASDAQ: KYNB)
 

Kyntra Bio Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Kyntra Bio Inc inventory turnover ratio, the Kyntra Bio Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.24 in the second quarter 2026, a new company high. Average inventory processing period, for the Kyntra Bio Inc in Jun 30 2026 quarter, has decreased to 294 days, compare to 299 days, in the Mar 31 2026 quarter.

Within Healthcare sector 291 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1568 in the first quarter 2026, to 1795.

KYNB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Kyntra Bio Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KYNB Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -12.4 % 7.26 % 18.64 % -83.86 % -84.79 %
Y / Y Cost of Sales Growth -97.65 % 1529.37 % - -22.67 % -39.29 %
Inventory Turnover Ratio (TTM) 1.24 1.22 0.18 -1.55 -0.64
KYNB's Total Ranking # 1795 # 1568 # 0 # #
Average inventory processing period 295 299 1983 -235 -573
Seq. Inventory Growth 0 % -9.59 % -3.13 % 0.03 % 22.44 %
Seq. Cost of Sales Growth -99.95 % 1376.98 % 379.31 % -31.76 % -66.27 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 81
Healthcare Sector # 292
Overall Market # 1795

Inventory Turnover Ratio Statistics
High Average Low
1.24 0.5 -1.55
(Jun 30 2026)   (Sep 30 2025)



KYNB Company Profile >> Back to KYNB Efficiency Comparisons >> Compare KYNB Inventory Turnover Ratio to its Competitors

Financial Statements
Kyntra Bio Inc 's Inventories $ 3 Millions Visit KYNB's Balance sheet
Kyntra Bio Inc 's Cost of Revenues TTM $ 4 Millions Visit KYNB's Income Statement
What are KYNB's Sales? Visit KYNB's Sales by Segment

Other Inventory Turnover Ratios
Kyntra Bio Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
KYNB's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for KYNB's Competitors
Inventory Turnover Ratio for KYNB's Suppliers
Inventory Turnover Ratio for KYNB's Customers

You may also want to know
KYNB's Sales Growth Rates KYNB's Pe Price to earnings ratio KYNB's Receivables Turnover Ratio KYNB's Stock Quote
KYNB's Net Income Growth Rates KYNB's Ps Price to Sales ratio KYNB's Sales per Employee KYNB's Asset Turnover Ratio
KYNB's Net Margin KYNB's Pb Price to Book ratio KYNB's Financial Strength Ratios KYNB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Cadre Holdings inc   3.39 $ 399.991  Millions$ 118  Millions
Bausch Health Companies Inc   3.38 $ 3,783.000  Millions$ 1,120  Millions
Bellevue Life Sciences Acquisition Corp  3.38 $ 1.215  Millions$ 0  Millions
Evolus Inc   3.37 $ 105.904  Millions$ 31  Millions
Gilead Sciences Inc   3.35 $ 6,217.000  Millions$ 1,857  Millions
10x Genomics Inc   3.29 $ 184.539  Millions$ 56  Millions
Exelixis Inc   3.28 $ 85.665  Millions$ 26  Millions
Biofrontera Inc   3.28 $ 6.622  Millions$ 2  Millions
Becton Dickinson And Company  3.25 $ 11,161.000  Millions$ 3,429  Millions
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Iovance Biotherapeutics inc   3.09 $ 167.681  Millions$ 54  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Akebia Therapeutics Inc   2.96 $ 44.632  Millions$ 15  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.